|
시장보고서
상품코드
2008165
베타 카테닌 시장 : 유형별, 용도별, 지역별Beta Catenin Market, By Type (BBI-801, Exisulind, M-102, Nefopam Hydrochloride, Others), By Application (Dermatology ,Oncology ,Genetic Disorder, Others), By Geography (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) |
||||||
베타 카테닌 시장은 2026년에 35억 9,400만 달러로 추정되고 있으며, 2033년까지 68억 2,200만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 11.2%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 35억 9,400만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2026-2033년) | 11.20% | 예측 금액(2033년) | 68억 2,200만 달러 |
베타 카테닌이라는 단백질은 배아의 성장과 발달에 필수적입니다. 인간의 CTNNB1 유전자는 단백질인 카테닌 베타를 암호화하고 있습니다. 베타 카테닌-1이라고도 불리는 베타 카테닌-1은 두 가지 기능을 가진 단백질로, 세포의 조절 및 조절, 유전자 전사, 세포 접착에 관여합니다. 또한 이 단백질은 세포 접착을 촉진하여 뼈와 피부와 같은 구조의 발달에 필수적인 역할을 합니다. 세포내 유전자의 활성은 일부 베타 카테닌에 의해 조절됩니다. 베타 카테닌은 전사 인자라고 불리는 특정 분자에 결합하여 작용하며, 이 전사 인자는 데옥시리보핵산(DNA)에 결합하여 배아가 완전한 인간으로 성장하는 방식에 영향을 미친다. 또한 베타 카테닌은 세포 분열과 증식을 조절합니다. 베타-카테닌은 핵내 Wnt 신호전달의 중요한 핵내 이펙터이며, 카도헬린에 기반한 접착 결합의 구조적 구성 요소이기도 합니다. 베타-카테닌의 구조적 및 신호 전달상의 불균형은 종종 전이 및 암과 관련된 질병 및 기능 장애 증식을 유발합니다. 표준 Wnt 캐스케이드의 주요 이펙터는 베타-카테닌이며, 이는 신호를 핵으로 전달하여 다양한 세포와 기관에서 세포의 운명 결정을 조절하는 Wnt 특이적 유전자의 전사를 유발합니다.
시장 역학
시장에서 활동하는 주요 기업은 암 환자 증가에 따라 예측 기간 중 시장 성장을 주도할 것으로 예상됩니다. 예를 들어 미국 암협회가 2022년 1월에 발표한 자료에 따르면 2022년 미국내 대장암 발병 건수는 약 10만 6,180건입니다. 또한 세계보건기구(WHO)가 2021년 3월에 발표한 자료에 따르면 2020년 전 세계에서 230만 명의 여성이 유방암 진단을 받았고, 68만 5,000명이 사망한 것으로 나타났습니다.
이 보고서의 주요 특징
- 세계의 베타 카테닌(베타 카테닌) 시장에 대해 조사 분석했으며, 2025년을 기준연도로 하여 예측 기간(2026-2033년) 시장 규모와 연평균 성장률(CAGR)을 조사 분석하여 전해드립니다.
- 또한 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트를 제공합니다.
- 세계의 베타 카테닌 시장의 주요 기업 개요을 회사 개요, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 다음과 같은 매개 변수를 기반으로 합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계의 베타 카테닌 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 베타 카테닌 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 베타 카테닌 시장 : 유형별(2026-2033년)
제5장 세계의 베타 카테닌 시장 : 용도별(2026-2033년)
제6장 세계의 베타 카테닌 시장 : 지역별(2026-2033년)
제7장 경쟁 구도
제8장 섹션
KSA 26.05.04Beta Catenin Market is estimated to be valued at USD 3,594 Mn in 2026 and is expected to reach USD 6,822 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3,594 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.20% | 2033 Value Projection: | USD 6,822 Mn |
A protein called beta-catenin is crucial for growth and development of embryos. The CTNNB1 gene in humans encodes the protein catenin beta. It is a protein with two functions that is also known as beta-catenin 1 and is involved in the control and coordination of cells, gene transcription, and cell adhesion. Additionally, it promotes cell adhesion, which is essential for the development of structures like bones and skin. The activity of genes in cells is regulated in part by beta-catenin. It functions by attaching to certain molecules known as transcription factors, which bind to Deoxyribonucleic acid (DNA) and influence how an embryo grows into a fully formed human being. Additionally, beta catenin regulates cell division and growth (proliferation). B-catenin is a crucial nuclear effector of canonical Wntsignaling in the nucleus and a structural component of cadherin-based adherens junctions. B-catenin structural and signaling imbalance frequently causes sickness and dysfunctional growth linked to metastasis and cancer. The primary effector in the canonical Wnt cascade is B-catenin, which transmits the signal to the nucleus and causes transcription of Wnt-specific genes that regulate cell fate decisions in a variety of cells and organs.
Market Dynamics
Key players operating in market are expected to drive the market growth during the forecast period, owing to increase in cancer patients. For instance, according to data published in January 2022, by the American Cancer Society, in 2022 in the U.S., there are about 106,180 cases of colon cancer. Moreover, according to data published on March 2021, by World Health Organization, states that, in 2020, there were 2.3 million women diagnosed with breast cancer globally and 685 000 deaths globally.
Key features of the study
- This report provides in-depth analysis of the global beta catenin market , and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global beta catenin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Boston Biomedical Inc, Dicerna Pharmaceuticals Inc., Marina Biotech Inc., Propanac Biopharma Inc, Warp Drive Bio Inc., prism pharma co ltd, , aileron therapeutics inc, MD2 Biosciences Inc, WntRx Pharmaceuticals Inc, Sapience Therapeutics Inc, and Venn Therapeutics LLC
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global beta catenin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global beta catenin market
Market Segmentation
- By Type
- BBI-801,
- Exisulind
- M-101
- Nefopam Hydrochloride
- Others
- By Application
- Dermatology
- Oncology
- Genetic Disorder
- Others
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Boston Biomedical Inc
- Dicerna Pharmaceuticals Inc.
- Marina Biotech Inc.
- Propanac Biopharma Inc
- Warp Drive Bio Inc.
- prism pharma co ltd.,
- aileron therapeutics inc.,
- MD2 Biosciences Inc.,
- WntRx Pharmaceuticals Inc.,
- Sapience Therapeutics Inc.,
- Venn Therapeutics LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Beta Catenin Market, By Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- BBI-801
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Exisulind
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- M-101
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Nefopam Hydrochloride
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
5. Global Beta Catenin Market, By Application, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Genetic Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
6. Global Beta Catenin Market, By Region, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Boston Biomedical Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Dicerna Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Marina Biotech Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Propanac Biopharma Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Warp Drive Bio Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- prism pharma co ltd
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- aileron therapeutics inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- MD2 Biosciences Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- WntRx Pharmaceuticals Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Sapience Therapeutics Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Venn Therapeutics LLC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
8. Section
- References
- Research Methodology
- About Us
(주말 및 공휴일 제외)
